EVP, Finance, Corporate Controller & Treasurer · Ovid Therapeutics Inc. (OVID)

Timothy Daly

FY2019 is the first fiscal year CompBrief holds for Timothy Daly as a named executive officer of Ovid Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$897,279

Salary $308,996Stock awards $0

3rd of 3 named executive officers at Ovid Therapeutics by FY2019 total.

3 named officers on file for Ovid Therapeutics, FY2019

Timothy Daly’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Ovid Therapeutics’s whole pay program stands against its peers

  • Ovid Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on OVID→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 24, 2020 (DEF 14A).

Free

Get Timothy Daly’s full pay file as a PDF — free

More than this page: up to 10 years of Timothy’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Timothy Daly compensation by year

Ovid Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Ovid Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019
Salary$308,996
Bonus$0
Stock awards$0
Option awards$457,831
Non-equity incentive$115,157
Pension and deferred compensation$0
All other$15,295
Total$897,279

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Ovid Therapeutics Inc. DEF 14A filed April 24, 2020, accession 0001564590-20-018268, and prior-year filings.

How this page was built: the Ovid Therapeutics Inc. filed document, accession 0001564590-20-018268. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2020.

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
Option679—$6.26
Option7,558—$8.50
Option15,625—$9.18
Option5,625—$6.40
Option50,000—$1.89
Option25,000—$2.46
Option125,000—$4.42

Per the Outstanding Equity Awards at Fiscal Year-End table in Ovid Therapeutics Inc.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it.

Ovid Therapeutics’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
DPhil Jeremy LevinChief Executive Officer$3,008,980
Amit RakhitPresident & CMO$1,590,937
Timothy Daly · this pageEVP, Finance, Corporate Controller & Treasurer$897,279

The full Ovid Therapeutics compensation record

free company brief

This page is one person within Ovid Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Ovid Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Timothy Daly's compensation dossier · One-time report. No refunds.